Oppenheimer & Co’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-32,356
Closed -$3.31M 1607
2014
Q4
$3.31M Sell
32,356
-52,756
-62% -$5.06M 0.1% 254
2014
Q3
$7.36M Buy
85,112
+53,849
+172% +$4.77M 0.22% 110
2014
Q2
$2.82M Sell
31,263
-30,471
-49% -$2.28M 0.08% 276
2014
Q1
$4.55M Sell
61,734
-3,528
-5% -$246K 0.14% 182
2013
Q4
$4.44M Buy
65,262
+5,598
+9% +$364K 0.14% 179
2013
Q3
$3.64M Sell
59,664
-641
-1% -$39.1K 0.13% 202
2013
Q2
$3.36M Buy
+60,305
New +$3.49M 0.13% 193

Oppenheimer & Co's COV Position: Q1 2015 in Review

Oppenheimer & Co sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 32,356 shares — an estimated $3.31M sold.

Oppenheimer & Co first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $7.36M in Q3 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Oppenheimer & Co reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 32,356 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $3.31M.
  • Oppenheimer & Co first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Oppenheimer & Co's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $7.36M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Oppenheimer & Co's 13F filing for Q1 2015, filed 8 May 2015.